Capmatinib in Patients with METex14-Mutated Non-Small Cell Lung Cancer: GEOMETRY Mono-1 Asian Subgroup Analysis

被引：0

作者：

Han, J. ^{[1
]}

Wolf, J. ^{[2
]}

Garon, E. ^{[3
]}

Groen, H. ^{[4
]}

Heist, R. ^{[5
]}

Ang, M. ^{[6
]}

Ohashi, K. ^{[7
]}

Toyozawa, R. ^{[8
]}

Kim, T. M. ^{[9
]}

Hida, T. ^{[10
]}

Takeda, M. ^{[11
]}

Sugawara, S. ^{[12
]}

Chang, W. ^{[13
]}

Yu, C. ^{[14
]}

Moizumi, S. ^{[15
]}

Robeva, A. ^{[16
]}

Le Mouhaer, S. ^{[17
]}

Waldron-Lynch, M. ^{[18
]}

Agostinho, A. Chassot ^{[16
]}

Myers, A. ^{[16
]}

Nishio, M. ^{[19
]}

机构：

[1] Natl Canc Ctr, Gyeonggi Do, South Korea

[2] Univ Hosp Cologne, Cologne, Germany

[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[4] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands

[5] Massachusetts Gen Hosp, Boston, MA 02114 USA

[6] Natl Canc Ctr Singapore, Singapore, Singapore

[7] Okayama Univ Hosp, Okayama, Japan

[8] Kyushu Natl Canc Ctr, Fukuoka, Japan

[9] Seoul Natl Univ Hosp, Seoul, South Korea

[10] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan

[11] Kinki Univ Hosp, Osaka, Japan

[12] Sendai Kousei Hosp, Sendai, Miyagi, Japan

[13] Chang Gung Mem Hosp, Taoyuan, Taiwan

[14] Natl Taiwan Univ Hosp, Taipei, Taiwan

[15] Novartis Pharma KK, Tokyo, Japan

[16] Novartis Pharmaceut, E Hanover, NJ USA

[17] Novartis Pharma SAS, Rueil Malmaison, France

[18] Novartis Pharma Ag, Basel, Switzerland

[19] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期

关键词：

MET; Capmatinib; NSCLC;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P85.04

引用

页码：S670 / S670

页数：1